A computational approach identifies two regions of Hepatitis C Virus E1 protein as interacting domains involved in viral fusion process

BMC Structural Biology

Volumn 9, Issue , 2009, Pages

  Bruni, Roberto ^a   Costantino, Angela ^a   Tritarelli, Elena ^a   Marcantonio, Cinzia ^a   Ciccozzi, Massimo ^a   Rapicetta, Maria ^a   El Sawaf, Gamal ^b   Giuliani, Alessandro ^a   Ciccaglione, Anna Rita ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GLYCOPROTEIN E1; VIRUS FUSION PROTEIN; E1 PROTEIN, HEPATITIS C VIRUS; VIRUS ENVELOPE PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GENETIC DRIFT; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HYDROPHOBICITY; MATHEMATICAL COMPUTING; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN DOMAIN; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SEQUENCE ALIGNMENT; VIRUS ENVELOPE; VIRUS STRAIN; BIOLOGY; CHEMISTRY; GENETICS; MUTATION; PHYSIOLOGY; PROTEIN DATABASE; SEQUENCE ANALYSIS; VIRUS ENTRY;

HEPATITIS C VIRUS;

COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; GENOTYPE; HEPACIVIRUS; MUTATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; SEQUENCE ANALYSIS, PROTEIN; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRUS INTERNALIZATION;

EID: 69549084780     PISSN: None     EISSN: 14726807     Source Type: Journal    
DOI: 10.1186/1472-6807-9-48     Document Type: Article

References (40)

1. Unravelling hepatitis C virus replication from genome to function. BD Lindenbach CM Rice, Nature 2005 436 933 938 10.1038/nature04077 16107832 (Pubitemid 41191668)
2. Hepatitis C virus entry: potential receptors and their biological functions. L Cocquerel C Voisset J Dubuisson, J Gen Virol 2006 87 Pt 5 1075 1084 10.1099/vir.0.81646-0 16603507
3. Hepatitis C virus entry depends on clathrin-mediated endocytosis. E Blanchard S Belouzard L Goueslain T Wakita J Dubuisson C Wychowski Y Rouillé J Virol 2006 80 6964 6972 16809302 10.1128/JVI.00024-06 (Pubitemid 44025195)
4. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. D Lavillette B Bartosch D Nourrisson G Verney FL Cosset F Penin EI Pécheur, J Biol Chem 2006 281 3909 3917 10.1074/jbc.M509747200 16356932 (Pubitemid 43847814)
5. Virus membrane-fusion proteins: more than one way to make a hairpin. M Kielian FA Rey, Nat Rev Microbiol 2006 4 67 76 10.1038/nrmicro1326 16357862 (Pubitemid 43135288)
6. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. S Bressanelli K Stiasny SL Allison EA Stura S Duquerroy J Lescar FX Heinz FA Rey, EMBO J 2004 23 728 738 14963486 10.1038/sj.emboj.7600064 (Pubitemid 38425440)
7. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. DL Gibbons MC Vaney A Roussel A Vigouroux B Reilly J Lepault M Kielian FA Rey, Nature 2004 427 320 325 10.1038/nature02239 14737160 (Pubitemid 38133653)
8. Structure of the dengue virus envelope protein after membrane fusion. Y Modis S Ogata D Clements SC Harrison, Nature 2004 427 313 319 10.1038/nature02165 14737159 (Pubitemid 38133652)
9. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. D Lavillette EI Pécheur P Donot J Fresquet J Molle R Corbau M Dreux F Penin FL Cosset, J Virol 2007 81 8752 8765 17537855 10.1128/JVI.02642-06 (Pubitemid 47242848)
10. Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity. AR Ciccaglione A Costantino C Marcantonio M Equestre A Geraci M Rapicetta, J Gen Virol 2001 82 Pt 9 2243 2250 11514735
11. Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1. HE Drummer I Boo P Poumbourios, J Gen Virol 2007 88 Pt 4 1144 1148 10.1099/vir.0.82567-0 17374757 (Pubitemid 46523502)
12. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. M Flint JM Thomas CM Maidens C Shotton S Levy WS Barclay JA McKeating, J Virol 1999 73 6782 6790 10400776
13. Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins. RF Garry S Dash, Virology 2003 307 255 265 10.1016/S0042-6822(02)00065-X 12667795 (Pubitemid 36344160)
14. The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins. AJ Pérez-Berna MR Moreno J Guillén A Bernabeu J Villalaín, Biochemistry 2006 45 3755 3768 10.1021/bi0523963 16533059
15. Hepatitis C virus E1 protein induces modification of membrane permeability in E. coli cells. AR Ciccaglione C Marcantonio A Costantino M Equestre A Geraci M Rapicetta, Virology 1998 250 1 8 10.1006/viro.1998.9380 9770414 (Pubitemid 28471756)
16. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. J Bukh RH Purcell RH Miller, Proc Natl Acad Sci USA 1993 90 8234 8238 8396266 10.1073/pnas.90.17.8234
17. Analysis of the C-terminal membrane anchor domains of hepatitis C virus glycoproteins E1 and E2: toward a topological model. B Charloteaux L Lins H Moereels R Brasseur, J Virol 2002 76 1944 1958 11799189
18. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins. L Cocquerel A Op de Beeck M Lambot J Roussel D Delgrange A Pillez C Wychowski F Penin J Dubuisson, EMBO J 2002 21 2893 2902 12065403 10.1093/emboj/cdf295 (Pubitemid 34670374)
19. The pre-transmembrane region of the HCV E1 envelope glycoprotein Interaction with model membranes. AJ Pérez-Berná A Bernabeu MR Moreno J Guillén J Villalaín, Biochim Biophys Acta 2008 1778 2069 2080 10.1016/j.bbamem.2008.03.018 18424260
20. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry. Y Ciczora N Callens F Penin EI Pécheur J Dubuisson, J Virol 2007 81 2372 2381 17166909 10.1128/JVI.02198-06 (Pubitemid 46303354)
21. Co-evolution of proteins with their interaction partners. CS Goh AA Bogan M Joachimiak D Walther FE Cohen, J Mol Biol 2000 299 283 293 10.1006/jmbi.2000.3732 10860738 (Pubitemid 30694214)
22. Assigning protein functions by comparative genome analysis: protein phylogenetic profiles. M Pellegrini EM Marcotte MJ Thompson D Eisenberg TO Yeates, Proc Natl Acad Sci USA 1999 96 4285 4288 10200254 10.1073/pnas.96.8.4285 (Pubitemid 29190328)
23. Recurrence plots in the analysis of Complex Systems. N Marwan MC Romano M Thiel J Kurths, Physics Reports 2007 438 237 329 10.1016/j.physrep.2006.11.001
24. Nonlinear signal analysis methods in the elucidation of protein sequence-structure relationships. A Giuliani R Benigni JP Zbilut CL Webber Jr P Sirabella A Colosimo, Chem Rev 2002 102 1471 1492 10.1021/cr0101499 11996541 (Pubitemid 35377648)
25. Designing allosteric peptide ligands targeting a globular protein. KA Selz TI Samylova AM Samoylov VJ Vodyanov AJ Mandell, Biopolymers 2007 85 38 59 10.1002/bip.20607 17009317 (Pubitemid 46154818)
26. Prediction of binding sites in receptor-ligand complexes with the Gaussian Network Model. T Haliloglu E Seyrek B Erman, Phys Rev Lett 2008 100 228102 10.1103/PhysRevLett.100.228102 18643462
27. Recurrence quantification analysis reveals interaction partners in paramyxoviridae envelope glycoproteins. A Giuliani M Tomasi, Proteins 2002 46 171 176 10.1002/prot.10044 11807945 (Pubitemid 34052070)
28. Large contact surface interaction between proteins detected by time series analysis methods: case study on C-Phycocyanins. A Giuliani R Benigni M Colafranceschi I Chandrashekar SM Cowsik, Proteins Struct Funct And Genet 2003 51 299 310 10.1002/prot.10366 (Pubitemid 36397762)
29. Simulated point mutations in the alpha-chain of human fibrinogen support a role of the alpha C domain in the stabilization of fibrin gel. M Colafranceschi M Papi A Giuliani G Amiconi A Colosimo, Pathophysiol Haemost Thromb 2006 35 417 427 10.1159/000102048 17565234 (Pubitemid 46895715)
30. Remote protein homology detection using recurrence quantification analysis and amino acid physicochemical properties. Y Yang E Tantoso KB Li, J Theor Biol 2008 252 145 154 10.1016/j.jtbi.2008.01.028 18342336
31. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. J Bukh RH Purcell RH Miller, Proc Natl Acad Sci USA 1994 91 8239 8243 8058787 10.1073/pnas.91.17.8239 (Pubitemid 24253922)
32. Structure-related statistical singularities along protein sequences: a correlation study. M Colafranceschi A Colosimo JP Zbilut VN Uversky A Giuliani, J Chem Inf Model 2005 45 183 189 10.1021/ci049838m 15667144
33. Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus. JC Meunier RS Russell V Goossens S Priem H Walter E Depla A Union KN Faulk J Bukh SU Emerson RH Purcell, J Virol 2008 82 966 973 17977972 10.1128/JVI.01872-07
34. The effect of DeltaK280 mutation on the unfolded state of a microtubule binding repeat in Tau. A Huang CM Stultz, PLoS Comput Biol 2008 4 e1000155 18725924 10.1371/journal.pcbi.1000155
35. An N-terminal amphipathic helix in Hepatitis C Virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. M Elazar P Liu CM Rice JS Glenn, J Virol 2004 78 11393 11400 15452261 10.1128/JVI.78.20.11393-11400.2004 (Pubitemid 39299681)
36. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. HE Drummer P Poumbourios, J Biol Chem 2004 279 30066 30072 10.1074/jbc.M405098200 15136562 (Pubitemid 38937928)
37. Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. DK Chang SF Cheng EAB Kantchev CH Lin YT Liu, BMC Biology 2008 6 2 18197965 10.1186/1741-7007-6-2
38. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. JM Kilby S Hopkins TM Venetta B DiMassimo GA Cloud JY Lee L Alldredge E Hunter D Lambert D Bolognesi T Matthews MR Johnson MA Nowak GM Shaw MS Saag, Nat Med 1998 4 1232 1233 10.1038/3293 9809537 (Pubitemid 28512112)
39. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. C Wild T Greenwell T Matthews, AIDS Res Hum Retroviruses 1993 9 1051 1053 10.1089/aid.1993.9.1051 8312047
40. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region. DM Eckert PS Kim, Proc Natl Acad Sci USA 2001 98 11187 11192 11572974 10.1073/pnas.201392898 (Pubitemid 32928704)